Publication | Open Access

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial

ImmunodeficienciesImmunologyPlacebo-controlled TrialPoor PrognosisMultiple SclerosisMedicineGuillain-barré Syndrome